Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider and approve Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals has informed BSE that its Board of Directors will meet on Wednesday, July 23, 2025 at 2:00 PM. The key agenda is to consider and approve the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The trading window for designated persons has been closed since July 1, 2025 and will remain shut until July 25, 2025, i.e., 48 hours after the results are announced. The company is based in Hyderabad and is listed on BSE under scrip code 531015.
This is a routine procedural filing with no immediate impact on the stock. Investors should await the actual Q1 FY26 numbers on July 23, 2025 to assess the company's quarterly performance and any directional cues on growth or profitability.